Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities
Umme Ruman,1 Sharida Fakurazi,2,3 Mas Jaffri Masarudin,1,2,4 Mohd Zobir Hussein1 1Materials Synthesis and Characterization Laboratory, Institute of Advanced Technology (ITMA), Universiti Putra Malaysia, Serdang, Selangor 43400, Malaysia; 2Laboratory of Vaccine and Immunotherapeutics, Instit...
Guardado en:
Autores principales: | Ruman U, Fakurazi S, Masarudin MJ, Hussein MZ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f2eff56a63f54067bbba38e4ef55e4e2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics
por: Menglu Zhu, et al.
Publicado: (2021) -
Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics
por: Shen X, et al.
Publicado: (2017) -
Hybrid Inorganic-Organic Core-Shell Nanodrug Systems in Targeted Photodynamic Therapy of Cancer
por: Gauta Gold Matlou, et al.
Publicado: (2021) -
Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy
por: Zhang J, et al.
Publicado: (2017) -
Acoustically enhanced microfluidic mixer to synthesize highly uniform nanodrugs without the addition of stabilizers
por: Le NHA, et al.
Publicado: (2018)